UCN2 and neoplasm: At the same time, selective induction of CRHR2/Ucn2 signaling activityin the large intestine of patients with chronic inflammation, or in those predisposed to develop, by using targeted drugs, may hold a therapeutic impact in the resolution of the inflammation and eliminate the chances the benign disease to progress to malignancy.